RxDoctor Payments Data

Denise Martineau, APRN

Nurse Practitioner · Tulsa, OKNPI 1205920501

Payments from drug & device makers

$2,944in general payments, 2019–2025

Across 165 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$534
  • AstraZeneca$403
  • Astellas Pharma US Inc$292
  • Exact Sciences$185
  • Pfizer$183
  • Novo Nordisk$165
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,74493%
  • Education$2007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,944 in reported general payments places this provider in the 90th percentile of 824 nurse practitioner providers in Oklahoma.

See all nurse practitioner providers in Oklahoma

Medicare billing

Part B allowed, 2024
$36,645
Medicare patients
210
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$45,451
EliquisApixaban19$21,664
LinzessLinaclotide12$12,544
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,724
MyrbetriqMirabegron19$9,010
SymbicortBudesonide/Formoterol Fumarate16$3,910
Atorvastatin Calcium132$3,398
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,443
Losartan Potassium104$1,419
Gabapentin77$1,395
Colestipol Hcl11$1,176
Albuterol Sulfate HfaAlbuterol Sulfate41$1,146
Metoprolol Succinate48$1,105
Omeprazole49$1,103
Ipratropium Bromide23$1,084

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$165$45,45131 claims
PfizerEliquis$183$21,66419 claims
AbbVieLinzess$534$12,54412 claims
GSKTrelegy Ellipta$101$11,72414 claims
Astellas Pharma US IncMyrbetriq$292$9,01019 claims
AstraZenecaSymbicort$403$3,91016 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$18$986158 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 824 nurse practitioner providers in Oklahoma.

Other nurse practitioner in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →